JP ATC M05BX04 · updated 2 Nov 2026
Denosumab shortage in Japan
Is there a Denosumab shortage in Japan?
Yes. As of 2 Nov 2026, 1 Denosumab product is reported short in Japan, the first since 2 Sep 2026. No return date has been given. Main reason: active ingredient shortage.
Also short in Italy. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | デノスマブBS皮下注120mgRM「F」 limited | Fuji Pharma | 2 Sep 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.